The global anti-nuclear antibody testing market is at the forefront of modern immunology, providing the primary screening tool for identifying systemic autoimmune disorders. ANA tests detect autoantibodies that target the nucleus of a patient’s own healthy cells, serving as a critical indicator for conditions such as Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis, and...
Systemic lupus erythematosus represents one of the most complex autoimmune disorders affecting millions globally, characterized by the immune system attacking healthy tissues and organs. The therapeutic landscape for lupus has undergone significant transformation over recent years, driven by advances in understanding disease pathophysiology and the development of targeted biological...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek